Author:
Chen Long,Zhang Baixue,Zhou Pijun,Duan Yiping,He Chen,Zhong Wenyi,Wang Tianyi,Xu Shengtao,Chen Jichao,Yao Hong,Xu Jinyi
Funder
Double First Class University Plan
China Pharmaceutical University
National Natural Science Foundation of China
Fundamental Research Funds for the Central Universities
Reference34 articles.
1. Cancer immunotherapies: advances and bottlenecks;Rui;Front Immunol,2023
2. Recent progress and future perspectives of immunotherapy in advanced gastric cancer;Jin;Front Immunol,2022
3. The foundations of immune checkpoint blockade and the ipilimumab approval decennial;Korman;Nat Rev Drug Discov,2022
4. Immunotherapy in multiple myeloma;Jadoon;Cancer Treat Res Commun,2021
5. Clinical implications of T cell exhaustion for cancer immunotherapy;Chow;Nat Rev Clin Oncol,2022